Cowen Inc’s Immunogen Inc IMGN Stock Holding History

Cowen Inc’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-90,000	Closed	-$1.32M	–	247
2013 Q4	$1.32M	Sell	90,000 -3,700	-4%	-$56.9K	0.22%	105
2013 Q3	$1.59M	Buy	+93,700	New	+$1.65M	0.24%	69

Other funds holding IMGN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cowen Inc's IMGN Position: Q1 2014 in Review

Cowen Inc sold out of Immunogen Inc (IMGN) in Q1 2014, closing a stake of 76,658 shares — an estimated $1.13M sold.

Cowen Inc first reported a position in IMGN in Q3 2013 and held it in 2 quarters. The position peaked at $1.13M in Q4 2013. 142 funds tracked by Wall St. Rank hold IMGN as of Q1 2014.

Cowen Inc reported no remaining Immunogen Inc position as of Q1 2014 after selling out during the quarter.
Cowen Inc sold 76,658 Immunogen Inc shares in Q1 2014, an estimated $1.13M.
Cowen Inc first reported a position in Immunogen Inc in Q3 2013 and held it in 2 quarters.
Cowen Inc's Immunogen Inc position peaked at $1.13M in Q4 2013.
142 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2014.

Based on Cowen Inc's 13F filing for Q1 2014, filed 16 May 2014.